Lumida
/EMBC
⌘K
Embecta Corp

Embecta Corp

EMBC
$4.94USD+1.02%+0.05 today

MARKET CAP

279.9M

P/E (TTM)

2.6x

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$16

AI Summary

Stalk
StalkMedium

In a Stage 4 decline, EMBC shows exhaustion after the May capitulation, qualifying for a mean-reversion setup at intermediate-cycle lows. However, price remains extended below declining EMAs and the short-term trend is down, so immediate entry is unattractive. We will stalk for a clean consolidation resolution or a pullback into resistance zones before buying.

  • 9.02% dividend yield plus $41M Q3 free cash flow.
  • Q3 revenue up $50M sequentially, signaling operational recovery.
  • Q3 revenue $272M, down 8.1% YoY; U.S. sales dropped 24.6%.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.1B$1.1B$1.1B$1.1B
YoY %-0.8%+0.2%-3.8%
P / Sales1.5x0.8x0.7x0.8x
EV / Sales2.9x2.3x2.3x2.2x
Gross Profit, Adj.$774.9M$749.9M$735.2M$676.8M
YoY %-3.2%-2.0%-7.9%
Margin %68.6%66.9%65.5%62.6%
EV / Gross Profit4.3x3.4x3.5x3.5x
EBITDA, Adj.$400.2M$256.6M$203.0M$282.8M
YoY %-35.9%-20.9%+39.3%
Margin %35.4%22.9%18.1%26.2%
EV / EBITDA8.2x10.0x12.7x8.3x
EBIT$309.6M$221.5M$166.8M$242.1M
YoY %-28.5%-24.7%+45.1%
Margin %27.4%19.8%14.9%22.4%
EV / EBIT10.7x11.5x15.5x9.7x
Net Income$223.6M$70.4M$78.3M$95.4M
YoY %-68.5%+11.2%+21.8%
Net Margin19.8%6.3%7.0%8.8%
EPS (GAAP)$3.89$1.22$1.34$1.62
YoY %-68.6%+9.8%+20.9%